Varex Imaging (VREX) Cash from Operations Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -84.38% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 185.96% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 16.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.60% |
| 10 | Varex Imaging | 419.42 Mn | 345.02 Mn | 72.60 Mn | -109.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -109.04% |
| Jan 2, 2026 | -269.47% |
| Oct 3, 2025 | -69.50% |
| Jul 4, 2025 | -3.75% |
| Apr 4, 2025 | 435.48% |
| Jan 3, 2025 | -7.77% |
| Sep 27, 2024 | -45.01% |
| Jun 28, 2024 | -78.78% |
| Mar 29, 2024 | -88.64% |
| Dec 29, 2023 | 378.38% |
| Sep 29, 2023 | 175.44% |
| Jun 30, 2023 | 1,496.30% |
| Mar 31, 2023 | 428.92% |
| Dec 30, 2022 | -134.26% |
| Sep 30, 2022 | -66.21% |
| Jul 1, 2022 | -112.22% |
| Apr 1, 2022 | -164.84% |
| Dec 31, 2021 | 52.11% |
| Oct 1, 2021 | 528.81% |
| Jul 2, 2021 | 1,909.09% |
| Apr 2, 2021 | 1,322.22% |
| Jan 1, 2021 | -69.13% |
| Oct 2, 2020 | -151.53% |
| Jul 3, 2020 | -93.17% |
| Apr 3, 2020 | -93.02% |
| Jan 3, 2020 | 15.00% |
| Sep 27, 2019 | 23.78% |
| Jun 28, 2019 | -24.41% |
| Mar 29, 2019 | 138.89% |
| Dec 28, 2018 | -50.12% |
| Sep 28, 2018 | 20.13% |
| Jun 29, 2018 | -20.52% |
| Mar 30, 2018 | -60.87% |
| Dec 29, 2017 | 108.85% |
| Sep 29, 2017 | -22.22% |
| Jun 30, 2017 | -2.55% |
| Mar 31, 2017 | -33.65% |
| Dec 30, 2016 | 214.75% |